The FDA has issued multiple warning letters to Empower over the past several years, documenting concerns about sterile compounding practices, contamination control, and quality assurance procedures
Trial Registration University Hospital Medical Information Network Clinical Trial Registry (UMIN-CTR) number: UMIN000045003
Two stars: 85 reviews (4%)
In women, this may occasionally manifest as menstrual irregularities
[1] [2] However, it's important to note that short-term use is unlikely to cause significant nutritional deficiencies in most patients
The authors found that GLP-1 RA use was associated with a significantly decreased risk of developing dry AMD compared with patients taking metformin (HR = .68), insulin (HR = .72), and statins (HR = .70)